Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Data Brief ; 35: 106930, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33748366

ABSTRACT

We describe here a multiproxy dataset (grain size, environmental magnetism, stable carbon isotope, total nitrogen, and total organic carbon) generated on a ~116 cm long trench profile from the high altitude alpine Badnikund lake in the Central Himalaya. The dataset also includes environmental magnetic and organic geochemistry data on catchment soils of the Bednikund lake. The presented data is related to the research article "Middle Holocene Indian summer monsoon variability and its impact on cultural changes in the Indian subcontinent" [1]. The chronology of the Bednikund lake trench (BBK) profile is well established with seven AMS 14C dates. The multiproxy data is provided in tabular format in an excel file along with ages in Mendeley Data Repository. The multiproxy data can be significantly utilized for regional correlation of Indian summer monsoon (ISM) variability during the middle Holocene as well as for correlation of global climatic events. The data can also be reutilized in paleoclimate modelling for precipitation change over the past ~6000 years.

2.
PLoS Pathog ; 16(5): e1008356, 2020 05.
Article in English | MEDLINE | ID: mdl-32437421

ABSTRACT

Tuberculosis (TB) is one of the deadliest diseases, claiming ~2 million deaths annually worldwide. The majority of people in TB endemic regions are vaccinated with Bacillus Calmette Guerin (BCG), which is the only usable vaccine available. BCG is efficacious against meningeal and disseminated TB in children, but protective responses are relatively short-lived and fail to protect against adult pulmonary TB. The longevity of vaccine efficacy critically depends on the magnitude of long-lasting central memory T (TCM) cells, a major source of which is stem cell-like memory T (TSM) cells. These TSM cells exhibit enhanced self-renewal capacity as well as to rapidly respond to antigen and generate protective poly-functional T cells producing IFN-γ, TNF-α, IL-2 and IL-17. It is now evident that T helper Th 1 and Th17 cells are essential for host protection against TB. Recent reports have indicated that Th17 cells preserve the molecular signature for TSM cells, which eventually differentiate into IFN-γ-producing effector cells. BCG is ineffective in inducing Th17 cell responses, which might explain its inadequate vaccine efficacy. Here, we show that revaccination with BCG along with clofazimine treatment promotes TSM differentiation, which continuously restores TCM and T effector memory (TEM) cells and drastically increases vaccine efficacy in BCG-primed animals. Analyses of these TSM cells revealed that they are predominantly precursors to host protective Th1 and Th17 cells. Taken together, these findings revealed that clofazimine treatment at the time of BCG revaccination provides superior host protection against TB by increasing long-lasting TSM cells.


Subject(s)
BCG Vaccine/immunology , BCG Vaccine/metabolism , Clofazimine/pharmacology , Immunologic Memory/immunology , Animals , BCG Vaccine/pharmacology , Clofazimine/metabolism , Drug Therapy, Combination/methods , Female , Immunization, Secondary/methods , Immunogenicity, Vaccine/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/immunology , Stem Cells/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Tuberculosis/immunology , Tuberculosis, Pulmonary/immunology
3.
Front Immunol ; 6: 440, 2015.
Article in English | MEDLINE | ID: mdl-26388868

ABSTRACT

Human influenza A viruses have been the cause of enormous socio-economic losses worldwide. In order to combat such a notorious pathogen, hemagglutinin protein (HA) has been a preferred target for generation of neutralizing-antibodies as potent therapeutic/diagnostic agents. In the present study, recombinant anti-HA single chain variable fragment antibodies were constructed using the phage-display technology to aid in diagnosis and treatment of human influenza A virus infections. Spleen cells of mice hyper-immunized with A/New Caledonia/20/99 (H1N1) virus were used as the source for recombinant antibody (rAb) production. The antigen-binding phages were quantified after six rounds of bio-panning against A/New Caledonia/20/99 (H1N1), A/California/07/2009 (H1N1)-like, or A/Udorn/307/72(H3N2) viruses. The maximum phage yield was for the A/New Caledonia/20/99 (H1N1), however, considerable cross-reactivity was observed for the other virus strains as well. The HA-specific polyclonal rAb preparation was subjected to selection of single clones for identification of high reactive relatively conserved epitopes. The high-affinity rAbs were tested against certain known conserved HA epitopes by peptide ELISA. Three recombinant mAbs showed reactivity with both the H1N1 strains and one (C5) showed binding with all the three viral strains. The C5 antibody was thus used for development of an ELISA test for diagnosis of influenza virus infection. Based on the sample size in the current analysis, the ELISA test demonstrated 83.9% sensitivity and 100% specificity. Thus, the ELISA, developed in our study, may prove as a cheaper alternative to the presently used real time RT-PCR test for detection of human influenza A viruses in clinical specimens, which will be beneficial, especially in the developing countries.

SELECTION OF CITATIONS
SEARCH DETAIL
...